GSK-SCD117226

Study Sponsor: GSK

Study Title

A Randomized, Single-Blind, Dose-Rising Study to Evaluate the Safety, Tolerability and Preliminary Pharmacokinetics of Single and 14 Day Repeat Topical Applications of GSK1940029 Gel on the Intact Skin of Healthy Human Subjects

Medicine or Vaccine (generic name)

GSK1940029

Sponsor Identification Number

SCD117226

Trial Registry Identification Number(#'s)

NCT01938482

Medical Condition

Acne Vulgaris

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=117226

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01938482

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

The data for this study is available in CDISC format.

Date Added to this Site

March 2019